• Science
  • Pipeline
  • About Us
  • News & Media
  • Resources
  • Investors
  • Contact Us
TheraCryf
  • Science
  • Pipeline
  • About Us
  • News & Media
  • Resources
  • Investors
  • Contact Us
Mobile close button Mobile toggle button

2021 Placing and Open Offer shareholder circular

steve | 2 February 2021
Categories:

Post navigation

← The novel atypical dopamine transport inhibitor CT-005404 has pro-motivational effects in neurochemical and inflammatory models of effort-based dysfunctions related to psychopathology
2021 Placing form of proxy →
  • Privacy Policy
  • Data Protection Complaints Handling Process
  • Sitemap
Get in touch
LinkedIn

© 2026 TheraCryf. ICO Reg: ZB396415. Company Number: 09246681.